Hypoglycemia per se stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia

Diabetes

Volumn 48, Issue 7, 1999, Pages 1429-1436

  Paramore, Deanna S ^a   Fanelli, Carmine G ^a   Shah, Suresh D ^a   Cryer, Philip E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; NORADRENALIN;

ADRENAL MEDULLA; ADRENALIN BLOOD LEVEL; ADRENERGIC TRANSMISSION; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOREARM; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; MALE; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ADRENAL MEDULLA; ADULT; C-PEPTIDE; CASE-CONTROL STUDIES; FEMALE; FOREARM; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIA; INSULIN; MALE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0032990417     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.7.1429     Document Type: Article

References (74)

1. Reichard P, Berglund B, Britz A, Cars I, Nilsson B-Y, Rosenqvist U: Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 230:101-108, 1991
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Cryer PE: Hypoglycemia in diabetes mellitus. In Hypoglycemia: Pathophysiology, Diagnosis and Treatment. New York/Oxford, Oxford University Press, 1997, p. 91-125
4. Egger M, Davey Smith G, Stettler C, Diem P: Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 14:919-928, 1997
5. Cryer PE: Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes 41:255-260, 1992
6. Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 91:819-828, 1993
7. Rattarasarn C, Dagogo-Jack SE, Zachwieja JJ, Cryer PE: Hypoglycemia-induced autonomic failure in IDDM is specific for the stimulus of hypoglycemia and is not attributable to prior autonomic activation. Diabetes 43:809-818, 1994
8. Dagogo-Jack SE, Rattarasarn C, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43:1426-1434, 1994
9. Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226, 1991
10. Davis M, Shamoon H: Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab 73:995-1001, 1991
11. Widom B, Simonson DC: Intermittent hypoglycemia impairs glucose counterregulation. Diabetes 41:1597-1602, 1992
12. Davis MR, Mellman M, Shamoon H: Further defects in counterregulatory responses induced by recurrent hypoglycemia in type I diabetes. Diabetes 41:1335-1340, 1992
13. Lingenfelser T, Renn W, Sommerwerck U, Jung MF, Buettner UW, Zaiser-Kaschel H, Kaschel R, Eggstein M, Jakober B: Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients. Diabetes 42:610-618, 1993
14. Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS: Intensive insulin therapy reduces counterregulatory responses to hypoglycemia in patients with type I diabetes. Ann Intern Med 103:184-190, 1985
15. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS: Defective glucose counterregulation after strict glycemic control of insulin dependent diabetes mellitus. N Engl J Med 316:1376-1383, 1987
16. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV: Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901-907, 1988
17. Bottini P, Boschetti E, Pampanelli S, Ciofetta M, Del Sindaco P, Scionti L, Brunetti P, Bolli GB: Contribution of autonomie neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM. Diabetes 46:814-823, 1997
18. Maran A, Lomas J, Macdonald IA, Amiel SA: Lack of protection of higher brain function during hypoglycaemia in patients with intensively treated IDDM. Diabetologia 38:1412-1418, 1995
19. Hopkins D, Evans M, Lomas J, Pernet A, Amiel S: Variable effect of previous glycemic experience on cognitive function and symptoms of hypoglycemia (Abstract). Diabetes 47:110A, 1998
20. Amiel SA: Cognitive function testing in studies of acute hypoglycaemia: rights and wrongs? Diabetologia 41:713-719, 1998
21. Fanelli CG, Pampanelli S, Porcellati F, Bolli GB: Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans. Diabetologia 41:720-723, 1998
22. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich JE: Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 42:1233-1237, 1993
23. Fanelli C, Pampanelli S, Ciofetta M, Lalli C, Del Sindaco P, Lepore M, Brunetti P, Bolli G: Effect of duration of recent, antecedent hypoglycemia in humans (Abstract). Diabetes 46:41A, 1997
24. Ovalle F, Fanelli CG, Paramore DS, Craft S, Cryer PE: Brief twice weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes. Diabetes 47:1472-1479, 1998
25. Fanelli CG, Paramore DS, Hershey T, Terkamp C, Ovalle F, Craft S, Cryer PE: Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes mellitus. Diabetes 47:1920-1927, 1998
26. Paramore DS, Fanelli CG, Shah SD, Cryer PE: Forearm norepinephrine spillover during standing, hyperinsulinemia and hypoglycemia Am J Physiol 275:E872-E881, 1998
27. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R: Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 98:580-691, 1996
28. Davis SN, Shavers C, Davis B, Costa F: Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest 100:429-438, 1997
29. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F: Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46:1328-1335, 1997
30. Wallin BG: Peripheral sympathetic neural activity in conscious humans. Annu Rev Physiol 50:565-576, 1988
31. Rea RF, Eckberg DL, Fritsch JM, Goldstein DS: Relation of plasma norepinephrine and sympathetic traffic during hypotension in humans. Am J Physiol 258:R982-R986, 1990
32. Grassi G, Bolli G, Seravalle G, Turri C, Lanfranchi A, Mancia G: Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci 92:285-289, 1997
33. Grossman E, Rea RF, Hoffman A, Goldstein DS: Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol 260:R142-R147, 1991
34. Schwartz NS, Clutter WE, Shah SD, Cryer PE: Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777-781, 1987
35. Marker JC, Cryer PE, Clutter WE: Simplified measurement of norepinephrine kinetics: application to studies of aging and exercise training. Am J Physiol 267:E380-E387, 1994
36. Clemson B, Gaul L, Gubin SS, Campsey DM, McConville J, Nussberger J, Zellis R: Prejunctional angiotensin II receptors: facilitation of norepinephrine release in the human forearm. J Clin Invest 93:684-691, 1994
37. Lembo G, Capaldo B, Rendina V, Iaccarino G, Napoli R, Guida R, Trimarco B, Saccá L: Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol 266:E242-E247, 1994
38. Greenfield ADM, Whitney RJ, Mowbray JF: Methods for the investigation of peripheral blood flow. Br Med Bull 19:101-109, 1963
39. Shah SD, Clutter WE, Cryer PE: External and internal standards in the single isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine in normal humans and patients with diabetes mellitus or chronic renal failure. J Lab Clin Med 106:624-629, 1985
40. Kuzkuya H, Blix P, Horwitz D, Steiner D, Rubenstein A: Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22-29, 1977
41. Ensinck J: Immunoassays for glucagon. In Glucagon Handb Exp Pharmacol. Vol 66. Lefebrve P, Ed. New York, Springer Verlag, 1983, p. 203-221
42. Gingerich RL, Lacy PE, Chance RE, Johnson MG: Regional pancreatic concentration and in vitro secretion of canine pancreatic polypeptide, insulin, and glucagon. Diabetes 27:96-101, 1978
43. Farmer RW, Pierce C: Plasma cortisol determination: radioimmunoassay and competitive protein binding compared. Clin Chem 20:411-414, 1974
44. Schalch D, Parker M: A sensitive double antibody radioimmunoassay for growth hormone in plasma. Nature 703:1141-1142, 1964
45. Hosaka K, Kikuchi T, Mitsuhida N, Kawaguchi A: A new colorimetric method for the determination of free fatty acids with acyl-CoA synthetase and acyl-CoA oxidase. J Biochem (Tokyo) 89:1799-1803, 1981
46. Pinter J, Hayaski J, Watson J: Enzymatic assay of glycerol, dihydroxyacetone and glyceraldehyde. Arch Biochem Biophys 121:404-414, 1967
47. Lowry O, Passoneau J, Hasselberger F, Schultz D: Effect of ischemia on known substrates and co-factors of the glycolyptic pathway of the brain. J Biol Chem 239:18-30, 1964
48. Cahill G, Herrera M, Morgan A, Soeldner J, Steinke J, Levy P, Reichard G, Kipnis D: Hormone-fuel interrelationships during fasting. J Clin Invest 45: 1751-1769, 1966
49. Towler DA, Havlin CE, Craft S, Cryer PE: Mechanism of awareness of hypoglycemia: perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 42:1791-1798, 1993
50. Frandsen HA, Snitker S, Christensen NJ, Madsbad S: No differential effects of porcine and human insulin on muscle sympathetic nerve activity during euglycemia or hypoglycemia. Clin Physiol 16:9-21, 1996
51. Anderson EA, Hoffman RP, Baton TW, Sinkey CA, Mark AL: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87:2246-2252, 1991
52. Berne C, Fagius J: Metabolic regulation of sympathetic nervous system activity: lessons from intraneural nerve recordings. Int J Obes Relat Metab Disord 17 (Suppl. 3):S2-S6, 1993
53. Spraul M, Ravussin E, Baron AD: Lack of relationship between muscle sympathetic nerve activity and skeletal muscle vasodilation in response to insulin infusion. Diabetologia 39:91-96, 1996
54. Tack CJJ, Smits P, Willemsen JJ, Lenders JWM, Thien T, Lutterman JA: Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes 45:15-22, 1996
55. Vollenweider L, Tappy L, Owlya R, Jequier E, Nicod P, Scherrer U: Insulin-induced sympathetic activation and vasodilation in skeletal muscle: effects of insulin resistance in lean subjects. Diabetes 44:641-645, 1995
56. Maggs DG, Jacob R, Rife F, Caprio S, Tamborlane WV, Sherwin RS: Counter-regulation in peripheral tissues: effects of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue. Diabetes 46:70-76, 1997
57. Cersosimo E, Garlick P, Feretti J: Renal glucose production during insulin-induced hypoglycemia in humans. Diabetes 48:261-266, 1998
58. Shah SD, Tse TF, Clutter WE, Cryer PE: The human sympathochromaffin system. Am J Physiol 247:E380-E384, 1984
59. Morgan DA, Baton TW, Ginsberg BH, Mark AL Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. Am J Physiol 264: R423-R427, 1993
60. Esler M, Jennings G, Lambert G, Meredith I, Home M, Eisenhofer G: Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 70:963-985, 1990
61. Christensen NJ, Knudsen HH: Peripheral catecholaminergic function evaluated by norepinephrine measurements in plasma, extracellular fluid and lymphocytes, from nerve recordings and cellular responses. In Catecholamines (Advances in Pharmacology, vol. 42). Goldstein DS, Eisenhofer G, McCarty R, Eds. San Diego, CA, Academic Press, 1998, p. 540-644
62. Cousineau D, Rose CP, Goresky CA: Plasma expansion effect on cardiac capillary and adrenergic exchange in intact dogs. J Appl Physiol 60:147-153, 1986
63. Jacobs M-C, Goldstein DS, Willemsen JJ, Smits P, Thien T, Lenders JM: Differential effects of low- and high-intensity lower body negative pressure on noradrenaline and adrenaline kinetics in humans. Clin Sci 90:337-343, 1996
64. Rea RF, Wallin BG: Sympathetic nerve activity in arm and leg muscles during lower body negative pressure in humans. J Appl Physiol 66:2778-2781, 1989
65. Vaz M, Turner A, Kingwell B, Chin J, Koft E, Cox H, Jennings G, Esler M: Postprandial sympatho-adrenal activity: its relation to metabolic and cardiovascular events and to changes in meal frequency. Clin Sci 89:349-357, 1995
66. Rea RF, Grossman E, Goldstein DS: Relation between sympathetic nerve activity and norepinephrine spillover in humans (Abstract). Clin Res 38:828A, 1990
67. Hoeldtke RD, Cilmi KM, Reichard GA Jr, Boden G, Owen EO: Assessment of norepinephrine secretion and production. J Lab Clin Med 101:772-782, 1983
68. Brown MJ, Jenner DA, Allison DJ, Dollery CT: Variations in individual organ release of noradrenaline measured by an improved radioenzymatic technique: limitations of peripheral venous measurements in the assessment of sympathetic nervous activity. Clin Sci 61:585-590, 1981
69. Planz G: Adrenaline and noradrenaline concentration in blood of suprarenal and renal vein of man with normal blood pressure and with essential hypertension. Klin Wochenschr 56:1109-1112, 1978
70. Goldstein DS, McCarty R, Polinsky RJ, Kopin IJ: Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension 5:552-559, 1983
71. Cryer PE: Isotope derivative measurements of plasma norepinephrine and epinephrine in man. Diabetes 25:1071-1082, 1976
72. Young JB, Landsberg L: Sympathoadrenal activity in fasted pregnant rats: dissociation of adrenomedullary and sympathetic nervous system responses. J Clin Invest 64:109-116, 1979
73. Young JB, Rosa RM, Landsberg L: Dissociation of sympathetic nervous system and adrenomedullary responses. Am J Physiol 247:E35-E40, 1984
74. Cryer PE: Diseases of the sympathochromaffin system. In Endocrinology and Metabolism. 3rd ed. Felig P, Baxter J, Frohman L, Eds. New York, McGraw-Hill, p. 713-748, 1995